Shanghai Blusail Boyuan Medical Technology

Shanghai Blusail Boyuan Medical Technology is a specialized medical technology company and a core subsidiary of Blue Sail Medical. The company functions as a strategic R&D and operational center focused on structural heart disease and minimally invasive cardiovascular interventions. Its portfolio features the Allegra transcatheter aortic valve replacement (TAVR) system, which is designed for treating symptomatic severe aortic valve stenosis. Additionally, the company supports the development and commercialization of advanced drug-eluting stents and balloon catheters within the broader group. By leveraging international R&D expertise from the parent group's global acquisitions, Blusail Boyuan aims to provide innovative solutions for the Chinese healthcare market. The company is headquartered in Shanghai and plays a pivotal role in Blue Sail Medical's high-end medical device expansion.